0 NYSE Companies - August 15, 2024Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2024Secured Medicare price assignment for theCompuFlo® Epidural System in multiple U.S. states Gross margin for the second quarter of 2024 […]Read More
0 NYSE Companies - August 15, 2024Brookfield Business Partners Announces Renewal of Normal Course Issuer Bids for Units and Exchangeable SharesBROOKFIELD, News, Aug. 15, 2024 (GLOBE NEWSWIRE) — Brookfield Business Partners (NYSE: BBU, BBUC; TSX: BBU.UN, BBUC) today announced that […]Read More
0 NYSE Companies - August 15, 2024Macerich Releases 2023 Corporate Responsibility ReportSANTA MONICA, Calif., Aug. 15, 2024 (GLOBE NEWSWIRE) — Macerich (NYSE: MAC), one of the nation’s leading owners, operators and […]Read More
0 NYSE Companies - August 15, 2024Solaris Reports 57m of 1.11% CuEq, 69m of 0.82% CuEq and 69m of 0.77% CuEq in Near Surface Results; Extends Mineralization North, Northwest and SoutheastVANCOUVER, British Columbia, Aug. 15, 2024 (GLOBE NEWSWIRE) — Solaris Resources Inc. (TSX: SLS; NYSE: SLSR) (“Solaris” or the “Company”) […]Read More
0 NYSE Companies - August 15, 2024Annovis Bio Reports Second Quarter Financial Results and Provides Business UpdateMALVERN, Pa., Aug. 15, 2024 (GLOBE NEWSWIRE) — via IBN — Annovis Bio Inc. (NYSE: ANVS) (“Annovis” or the “Company”), […]Read More
0 NYSE Companies - August 15, 2024Dillard’s, Inc. Reports Second Quarter and Year-to-Date ResultsLITTLE ROCK, Ark., Aug. 15, 2024 (GLOBE NEWSWIRE) — Dillard’s, Inc. (NYSE: DDS) (the “Company” or “Dillard’s”) announced operating results […]Read More
0 NYSE Companies - August 15, 2024Stantec selected by Los Angeles Department of Water & Power for 5-year US $104-million Master Services AgreementLOS ANGELES and EDMONTON, Alberta and NEW YORK, Aug. 15, 2024 (GLOBE NEWSWIRE) — TSX, NYSE:STN Stantec, a global leader […]Read More
0 NYSE Companies - August 15, 2024BiomX Reports Second Quarter 2024 Financial Results and Provides Business and Program UpdatesBiomX anticipates reporting important results in 2025 for two clinical assets from the Company’s leading phage therapy pipeline Recent stockholder […]Read More
0 NYSE Companies - August 15, 2024BiomX Inc. Announces 1-for-10 Reverse Stock SplitGAITHERSBURG, Md., Aug. 15, 2024 (GLOBE NEWSWIRE) — BiomX Inc. (NYSE American: PHGE) (“BiomX” or the “Company”), a clinical-stage company […]Read More
0 NYSE Companies - August 14, 2024CORRECTION — Ibotta Reports Second Quarter 2024 Financial ResultsDENVER, Aug. 14, 2024 (GLOBE NEWSWIRE) — In a release issued under the same headline August 13, 2024 by Ibotta […]Read More